Crossmark

Molecular diagnosis in non-small-cell lung cancer: expert opinion on <i>ALK</i> and <i>ROS1</i> testing

Crossref DOI link: https://doi.org/10.1136/jclinpath-2021-207490

Published Online: 2021-04-19

Published Print: 2022-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Conde, Esther https://orcid.org/0000-0002-0914-0988
Rojo, Federico

Gómez, Javier

Enguita, Ana Belén

Abdulkader, Ihab

González, Ana

Lozano, Dolores

Mancheño, Nuria

Salas, Clara

Salido, Marta

Salido-Ruiz, Eduardo

de Álava, Enrique
Funding

Funding for this research was provided by:

Pfizer
License Information

License valid from 2021-04-19